Wellgistics Health (NASDAQ:WGRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Friday.
Wellgistics Health Trading Down 3.6%
Shares of NASDAQ WGRX opened at $1.32 on Friday. Wellgistics Health has a 12-month low of $0.62 and a 12-month high of $7.04. The company has a debt-to-equity ratio of 11.16, a current ratio of 0.32 and a quick ratio of 0.11. The firm has a fifty day moving average of $0.98.
Wellgistics Health (NASDAQ:WGRX – Get Free Report) last posted its quarterly earnings data on Tuesday, August 19th. The company reported ($0.11) earnings per share for the quarter. The business had revenue of $7.79 million for the quarter.
Wellgistics Health Company Profile
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
Featured Articles
- Five stocks we like better than Wellgistics Health
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Lululemon Share Price Has Plenty of Room Left to Fall
- Following Congress Stock Trades
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
